Delivery Order SPE2DB22D3010-SPE2DB25FP2KW
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has a firm fixed price of $14,552.43 and a completion date of May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,843.71 contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The contract has a firm fixed price and an ultimate completion date of January 8, 2025. This delivery order is associated with a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,248.34 firm fixed-price contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of January 18, 2024 and was awarded on January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,728.30, is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 firm fixed-price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL, a medication used to manage diabetes. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,321.28, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract is for a firm fixed price and has an ultimate completion date of January 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $5,774.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to manage diabetes. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,893.70, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The contract has a completion date of June 11, 2024 and a firm fixed-price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,342.41, is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,448.13 firm fixed-price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has a completion date of January 7, 2025 and was awarded on January 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...